全文获取类型
收费全文 | 21482篇 |
免费 | 1607篇 |
国内免费 | 452篇 |
专业分类
耳鼻咽喉 | 264篇 |
儿科学 | 569篇 |
妇产科学 | 589篇 |
基础医学 | 3499篇 |
口腔科学 | 353篇 |
临床医学 | 2394篇 |
内科学 | 4151篇 |
皮肤病学 | 1317篇 |
神经病学 | 1442篇 |
特种医学 | 450篇 |
外国民族医学 | 1篇 |
外科学 | 1490篇 |
综合类 | 1362篇 |
一般理论 | 5篇 |
预防医学 | 2324篇 |
眼科学 | 201篇 |
药学 | 1754篇 |
6篇 | |
中国医学 | 142篇 |
肿瘤学 | 1228篇 |
出版年
2024年 | 28篇 |
2023年 | 393篇 |
2022年 | 861篇 |
2021年 | 1028篇 |
2020年 | 1026篇 |
2019年 | 910篇 |
2018年 | 849篇 |
2017年 | 786篇 |
2016年 | 767篇 |
2015年 | 848篇 |
2014年 | 1396篇 |
2013年 | 1642篇 |
2012年 | 1069篇 |
2011年 | 1252篇 |
2010年 | 943篇 |
2009年 | 986篇 |
2008年 | 992篇 |
2007年 | 917篇 |
2006年 | 852篇 |
2005年 | 674篇 |
2004年 | 599篇 |
2003年 | 514篇 |
2002年 | 394篇 |
2001年 | 355篇 |
2000年 | 327篇 |
1999年 | 349篇 |
1998年 | 277篇 |
1997年 | 270篇 |
1996年 | 242篇 |
1995年 | 228篇 |
1994年 | 199篇 |
1993年 | 179篇 |
1992年 | 192篇 |
1991年 | 143篇 |
1990年 | 124篇 |
1989年 | 117篇 |
1988年 | 118篇 |
1987年 | 97篇 |
1986年 | 67篇 |
1985年 | 107篇 |
1984年 | 88篇 |
1983年 | 52篇 |
1982年 | 47篇 |
1981年 | 53篇 |
1980年 | 48篇 |
1979年 | 37篇 |
1978年 | 21篇 |
1977年 | 19篇 |
1976年 | 25篇 |
1975年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
132例男性不育患者遗传学病因分析 总被引:3,自引:0,他引:3
目的:对男性不育患者进行遗传学病因分析,并探讨其遗传效应。方法:采取132例男性不育患者外周血进行染色体核型分析。结果:132例男性不育患者中,染色体异常24例,染色体变异22例。其中大Y20例,47,XXY18例,45.XY,t(13;14)3例,小Y和46,XY,inv(9)各2例,46,XY,t(9;22)1例。结论:染色体异常是男性不育的重要原因,并建议男性不育患者进行基因诊断,以便确诊是否属于遗传病,为生育提供指导,避免盲目治疗。 相似文献
32.
C. S. Peretti J. M. Danion F. Kauffmann-Muller D. Grangé A. Patat P. Rosenzweig 《Psychopharmacology》1997,129(4):329-338
Buprenorphine is a mu opioid partial agonist currently used as an analgesic, and being developed for the treatment of opioid
dependence. The purpose of this study was to determine the abuse liability of parenteral buprenorphine in volunteers maintained
on daily sublingual (SL) buprenorphine (8 mg). In a residential laboratory, eight volunteers underwent pharmacologic challenges
two times per week. Medication challenges were 16 h after the daily dose of buprenorphine, and consisted of double-blind IM
injections of buprenorphine (4, 8, 16 mg), the prototypic mu opioid agonist hydromorphone (9 and 18 mg), or saline. Assessments
consisted of physiologic monitoring, subjects’ self-reports, and a trained observer’s ratings of drug effects, and were collected
for 0.5 h before and 2.0 h following injection. Supplemental doses of IM buprenorphine produced opioid agonist-like effects,
indicating some abuse potential of parenteral buprenorphine in buprenorphine-maintained patients. There was incomplete cross-tolerance
to the effects of hydromorphone, suggesting that higher maintenance doses of buprenorphine may be needed to maximize clinical
efficacy. However, there was a lack of graded dose-effects for hydromorphone, suggesting that buprenorphine’s combination
of partial agonist effects and high affinity for opioid receptors may limit the magnitude of effects of supplemental full
agonists. Finally, participants tolerated cumulative doses of maintenance buprenorphine plus challenge buprenorphine without
adverse effects, suggesting higher doses of buprenorphine can be safely administered to opioid dependent patients.
Received: 22 February 1996/Final version: 23 August 1996 相似文献
33.
Semi-structured interviews were conducted with a cohort of 22 test applicants who requested Huntington's disease (HD) predictive testing in South Wales, and a random sample of 32 non-requesters, drawn from the South Wales HD register. Apart from identifying differences between the groups, the study afforded the opportunity to listen, at length, to at-risk individuals' accounts of living at risk and their thoughts about predictive testing and genetic services. Emergent themes included difficulties in family communication and the uncertainties inherent in being at risk and undergoing testing. Important factors in decision making about testing were: moral imperatives to clarify one's genetic status; views about the controllability of the future; family attitudes and norms; and the impact of a test result on family members. At-risk individuals' perceptions of the genetics service were that contact with the service would result in pressure to be tested and a need for test applicants to present a favourable view of coping capacities to secure testing. In addition, there was an expectation of ongoing contact with HD families at the initiative of the service providers. Implications of the findings for the way in which predictive testing services are structured and introduced to the at-risk population are discussed. 相似文献
34.
Familial Sneddon's syndrome 总被引:4,自引:0,他引:4
Alexander Lossos Tamir Ben-Hur Ziva Ben-Nariah Claes Enk Moshe Gomori Dov Soffer 《Journal of neurology》1995,242(3):164-168
We report the familial occurrence and apparent autosomal dominant inheritance of Sneddon's syndrome with variable clinical expression. The proband, a 40-year-old woman, presented with livedo reticularis and progressive neurological deterioration following a stroke. The diagnosis was confirmed by cerebral angiogram and skin biopsy, both showing the characteristic findings. Two of the patient's sisters were reported to have been similarly affected in the past. Her mother, two additional siblings and five of her seven children exhibited various vasospastic skin phenomena. Familial aggregation of this disorder may be common and a genetic basis may be involved in its pathogenesis. 相似文献
35.
Guthrie and Buchwald (1991) proposed an ad hoc procedure for assessing the statistical significance of waveform difference potentials that may arise in a variety of psychophysiology research contexts. In our paper, an alternative method is presented and demonstrated that has fewer underlying assumptions than does the Guthrie-Buchwald test and may, therefore, produce better results in some situations. In particular, the test proposed here (a) is distribution free, (b) requires no assumption of an underlying correlation structure (e.g., first-order autoregressive), (c) requires no estimate of the population autocorrelation coefficient, (d) is exact, (e) produces p values for any number of subjects and time points, and (f) is highly intuitive as well as theoretically justifiable. This procedure may be used to carry out multiple comparisons with exact specification or experimentwise error, however, this test is based on permutation principles and may require large amounts of computer time for its implementation. 相似文献
36.
37.
The MIC values of the antifungal drug ketoconazole were evaluated on 66 Candida albicans strains. These strains were isolated from 26 HIV-1 infected patients with oral recurrent candidosis. Each episode of oral candidosis observed in these patients was orally treated with ketoconazole (200 mg/day) until the clinical disappearance of the lesions. The most frequent MIC values were 20 micrograms/ml and 10 micrograms/ml, observed in 37 and 19 isolates respectively. Only strains from five patients showed changes in their susceptibility to ketoconazole. This fact could indicate that a different strain causes the subsequent reappearance of the oral lesions, rather than the drug selecting resistant fungal strains. Our results stress the role of host characteristics in the occurrence of candidal infections, pointing to the progressing failure of the immunological response as the most important factor responsible for the recurrence of oral candidosis during HIV-1 infection. 相似文献
38.
R. J. Rona A. V. Swan R. Beech D. M. Wilson F. B. Kavanagh C. Brown C. Axtell S. Mandalia 《Clinical genetics》1992,42(4):186-195
For certain genetic conditions DNA testing identifies carriers and determines the risk status of foetuses, thus helping parents to make more informed prenatal decisions. Data, collected from three genetic centres in England and Wales from August 1986 to July 1990, are used to describe trends in demand for DNA testing, the impact of DNA tests on carrier risk assessment, and the use of DNA tests in relation to pregnancy outcome. Altogether the data include 23,388 subjects and 681 pregnancies in 8738 families divided into five cohorts by year of entry and referral. The most frequent gene disorders referred to the genetic centres are currently being tested or will soon be tested. For these disorders the initial high level of activity has declined and may have reached steady state. Demand for DNA services is high for cystic fibrosis and Duchenne muscular dystrophy, intermediate for Huntington's disease, and low for adult polycystic kidney disease, phenylketonuria and tuberous sclerosis. Based on these findings we suggest that demand for DNA tests will be high in serious, untreatable and slow progressing conditions with early onset; intermediate for conditions affecting intellect and neurological integrity with later onset; and low for treatable, late-onset conditions, or those for which there is evidence of heterogeneity, and variable penetrance. It would be helpful to assess the extent to which this view of demand is confirmed when the new disorders being DNA tested are considered and for the pattern of activity of DNA testing for some types of cancer. Since no DNA centre could offer a fully comprehensive testing service, it is recommended that a structure is created to audit overall activity, assist in policy formulation, and influence supraregional service organisation, in order that the spread of DNA services be planned as effectively as possible. This structure would facilitate monitoring of the evolution of contract specifications agreed by commissioners and providers on a regional basis. 相似文献
39.
Eugenio Baraldi Giovanni Montini Stefania Zanconato Graziella Zacchello Franco Zacchello 《Pediatric nephrology (Berlin, Germany)》1990,4(6):623-626
The aim of this study was to evaluate the effect of correction of chronic anaemia on the physical performance and the cardiovascular response to effort in children with end-stage renal disease (ESRD) maintained by haemodialysis. Seven patients (mean age 13.9 years) underwent triangular-type treadmill exercise testing before [haemoglobin (Hb) 6.3±0.9 g/dl] and after (Hb 11.2±1.2 g/dl) anaemia correction with recombinant human erythropoietin (rHuEPO). After treatment, the work-load reached, the peak oxygen uptake and average ventilatory anaerobic threshold (VAT) values were significantly increased (P<0.01,P<0.001,P<0.05 respectively). VAT values, expressed as a percentage of normal values, increased from 55.7±16.6% to 82.4±21%. This improvement correlated well with the increase in Hb (r=0.79). Oxygen pulse also increased significantly, when tested after anacmia correction. In conclusion, these data demonstrate that when the anaemia of children with ESRD is corrected with rHuEPO, there is a clear improvement in acrobic work capacity and effort tolerance. 相似文献
40.
Photopatch testing: a consensus methodology for Europe 总被引:1,自引:0,他引:1
D.P. Bruynzeel J. Ferguson K. Andersen M. Gonçalo John English A. Goossens E. Holzle S.H. Ibbotson M. Lecha P. Lehmann F. Leonard Harry Moseley P. Pigatto A. Tanew 《Journal of the European Academy of Dermatology and Venereology》2004,18(6):679-682
A group of interested European Contact Dermatologists/Photobiologists met to produce a consensus statement on methodology, test materials and interpretation of photopatch testing. While it is recognized that a range of local variables operate throughout Europe, the underlying purpose of the work is to act as an essential preamble to a Pan European Photopatch Test Study focusing particularly on sunscreen chemicals. 相似文献